Search
for
Sort by
Research 901–930 of 1000+
- Recent Advances in Genetically Engineered Mouse Models of Melanoma: Insights into Tumor Initiation and Oncogenic Signaling Pathways
- UHPLC-Q-Orbitrap HRMS-based Metabolomics and In Silico Studies on 5-α-Reductase, JAK1, JAK2, and JAK3 of <i>Albizia saponaria</i> L.: Application to Alopecia
- Research Progress on the Immunomodulatory Effects by Dang Gui (Radix Angelica sinensis) and Its Active Chemical Components
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Expression of Signal Transducer and Activator of Transcription-3 in Androgenetic Alopecia: A case control study
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- 33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2
- Stem cells supporting other stem cells
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- Exploring the Use of Topical Tofacitinib in Pediatric Alopecia Totalis
- Myeloproliferative disorder associated with alopecia universalis
- Therapeutic Response of Alopecia Areata‐Associated Nail Changes to Baricitinib
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Poster Presentations
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- Potential Treatment of Steroid‐Resistant Alopecia Areata Using Allogeneic Exosomes Derived From Adipose Tissue Mesenchymal Stromal Cells: A Case Report
- Treatment of longstanding alopecia areata universalis of the eyebrows/facial hair with oral and topical tofacitinib
- A transcriptomic map of murine and human alopecia areata
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Ruxolitinib found to cause eyelash growth: a case report
- Gut microbiome, metabolome and alopecia areata
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Efficacy and Safety of Switching from Baricitinib to Ritlecitinib in Severe Alopecia Areata
- Prescribing patterns amongst UK dermatologists for the treatment of alopecia areata, female pattern hair loss, and frontal fibrosing alopecia
- Upadacitinib for Alopecia Areata in Different Backgrounds: A Case Series